Enovix Chief Legal Officer Sells Shares Worth $13,193
Arthi Chakravarthy, Enovix's Chief Legal Officer, sold 2,221 shares on June 24, 2026.
Key Points
- Arthi Chakravarthy, Chief Legal Officer at Enovix, sold 2,221 shares at $5.94 each, totaling $13,192.74 on June 24, 2026.
- Enovix trades on NasdaqGS under the ticker ENVX, with a market cap of $1.32 billion and a 52-week range between $4.62 and $16.49.
- Analysts maintain a mix of 'buy' and 'hold' ratings, with price targets ranging from $6 to $25, while BlackRock increased its stake by 1.28 million shares.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Arthi Chakravarthy, the Chief Legal Officer at Enovix Corporation, sold 2,221 shares of the company on June 24, 2026. The transaction was executed at an average price of $5.94 per share, totaling $13,192.74. This sale was not part of a pre-planned trading program.
Insider Buying and Selling at Enovix Corporation
In addition to Chakravarthy's sale, several other insiders at Enovix have been active in the market. On June 18, 2026, President and CEO Rajendra Talluri sold 17,650 shares at $7.08 each. Earlier in June, Chief Accounting Officer Kristina Truong sold 1,015 shares at $6.66 per share. On the buying side, Joseph Ian Malchow, Pegah Ebrahimi, and Gregory Reichow each purchased 29,104 shares on June 11, 2026, with no price disclosed.
Other Institutional Activity in Enovix
Several institutional investors have adjusted their positions in Enovix. BlackRock, Inc. increased its holdings by 1,280,739 shares, reaching a total of 15,330,789 shares valued at approximately $79.4 million. Vanguard Capital Management LLC and Vanguard Portfolio Management LLC both opened new positions, acquiring 8,379,238 and 8,051,198 shares, respectively. UBS Group AG reduced its stake by 205,274 shares, ending with 5,770,071 shares valued at around $29.9 million. Geode Capital Management, LLC added 458,598 shares, bringing its total to 4,872,090 shares worth about $25.2 million.
Enovix Corporation Stock Up 77.1%
Shares of Enovix Corporation, trading under the ticker ENVX on the NasdaqGS, were priced near $5.93 as of Saturday. The company has a market capitalization of approximately $1.32 billion. Enovix's stock has a 52-week low of $4.62 and a high of $16.49. The 50-day moving average is $6.84, while the 200-day moving average is $7.74. The firm has a high current ratio of 10.97 and a quick ratio of 10.47, indicating strong liquidity.
$ENVX stock price
Daily closing prices, year to date. Not investment advice.
Analysts Set New Price Targets
On May 14, 2026, several analysts issued ratings on Enovix. Oppenheimer maintained a 'buy' rating with a price target of $21. Craig-Hallum also maintained a 'buy' rating, setting a target of $8. TD Cowen reiterated a 'hold' rating with a $7 target, while Benchmark maintained a 'buy' rating with a $15 target. The consensus among analysts is a target mean price of $13.10, with ten analysts contributing to this outlook.
About Enovix Corporation
Enovix Corporation designs and manufactures lithium-ion battery cells for various applications, including wearables, smartphones, and electric vehicles. Founded in 2006, the company is headquartered in Fremont, California, and is led by CEO Dr. Raj Talluri. With 664 employees, Enovix operates in the industrials sector, focusing on electrical equipment and parts.
Bottom Line
Arthi Chakravarthy's recent sale of Enovix shares is part of ongoing insider activity within the company. Investors often track such moves, though they do not necessarily indicate future performance. Enovix's stock remains under the watchful eye of institutional investors and analysts, with diverse opinions on its potential. Remember, insider transactions are reported after they occur and may not reflect the current holdings.
Get Enovix Corporation alerts
New 13F filings, insider trades, and analyst moves on $ENVX, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.